WELCOME TO THE FUTURE OF MEDICINE
QHSLab, Inc.
a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians.
QHSLab, Inc. (OTCQB: USAQ)
We are a medical device technology company that equips primary care physicians (PCPs) with the digital solutions needed to increase their practice revenues through value-based tools that evaluate and treat chronic disease.
Our products improve clinical outcomes for patients - often saving them the time and expense of a specialist visit while allowing physicians to increase their practice revenue through existing CPT reimbursement codes.
We provide our clients with the software and training necessary to improve clinical outcomes using value-based healthcare, informatics, and algorithmically personalized medicine to manage behavior-based, remote patient monitoring, chronic care, and preventive medicine.
We Develop Digital Medicine Tools That Help Primary Care Physicians.
Primary care doctors lack easy-to-use and reimbursable tools. Our cutting-edge model combines smart point-of-care and remote patient monitoring technology with clinically proven assessments of chronic conditions faced by millions of patients daily.
Our Vision.
We are led by a group of concerned doctors, academics, health professionals, informatics, and information technology professionals. Our vision is to see individuals take control of their health through physician-directed digital medicine and innovative, AI-enhanced, preventive health technologies that streamline the care process. Being healthy includes our physical condition and the state of our mental and social well-being.
Our Mission.
Our mission is to improve individuals' quality of life through physician-directed digital medicine and AI-enhanced preventive health technologies.
Connected, comprehensive systems for primary care.
Our products and services create a next-generation network and care system that supports primary care physicians with technology, innovative in-office procedures, and back-end systems that improve clinical outcomes and increase revenue for practices.
Our Products
Preventive Health Technologies for Primary Care Physicians
Medical Practice Income focuses on the frontline of healthcare - the primary care physician, equipping them with the digital medicine tools to sustain their practices, reduce burnout, and improve their patients' clinical outcomes. The #FutureofMedicine is prevention. Medical Practice Income enhances individuals and patient populations' quality of life through physician-directed, data-driven, AI-enhanced preventive health technologies.
Equipping Non-Allergy Specialist Physicians with Allergy Testing
AllergiEnd® equips non-allergy specialist physicians with one of the top ancillary services for their practice, allergy testing, and treatment. AllergiEnd's products are pain-free, provide quick results, and are designed for application in a primary care setting like a pediatrician's office or a family practitioner. With more than 50 million Americans suffering from allergies and only 5,000 allergy specialists in the United States, there is a critical need for more widespread and available allergy testing and treatment kits.
QHSLab: One Number, Countless Insights into Patient Health
This unique, cloud-based digital medicine platform supports physicians’ transitions to overall population health management and preventive healthcare. QHSLab calculates a patient’s Quality Health Score (the QHS), one number that gives both the healthcare provider and patient critical information about their health and identifies changeable opportunities to improve health and wellbeing. QHSLab is a high-level, fully automated, cloud-based Software as a Service (SaaS).
QHSLab, Inc.
Investment Thesis
The Future of Medicine is prevention, not just treatment.
QHSLab, Inc. is developing the tools that today’s physicians need to streamline their practices, improve clinical outcomes, and sustain their businesses with ongoing revenue. Our AI-enhanced virtual medicine and point of care tools empower physicians and their patients - improving the healthcare industry for all.
Press Releases
Investor Relations
Litchfield Hills Research has continually identified QHSLab, Inc. (Stock Symbol USAQ) as an "attractive" opportunity for those interested in digital medicine. Discover why an investment made today will shape the #FutureofMedicine for generations to come.
QHSLab, Inc. (USAQ) does not provide financial advice.
Forward-Looking Statements
Certain matters presented on this website are "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace, future revenues, future products, and potential future results and acquisitions are examples of such forward-looking statements. Forward-looking statements are generally identified by words such as "may," "could," "believes," "estimates," "targets," "expects," or "intends," and other similar words that express risks and uncertainties. These statements are subject to numerous risks and uncertainties, including, but not limited to, the timing of the introduction of new products, the inherent discrepancy in actual results from estimates, projections, and forecasts made by management, regulatory delays, changes in government funding and budgets, and other factors, including general economic conditions, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. None of USA Equities Corp Directors, Consultants, or any other person named with their consent in this website can assure you that any forward-looking statement or result expressed or implied by any forward-looking statement will be achieved.